Benzinga·9h ago·Vandana SinghImmunityBio Stock Surges on FDA Acceptance of Bladder Cancer Combo Therapy FilingImmunityBio shares rally 8.12% after FDA accepts bladder cancer therapy filing, with decision expected January 2027. IBRXFDA approvalbiotech
Benzinga··Vandana Singh